{"id":866626,"date":"2025-07-03T17:33:20","date_gmt":"2025-07-03T21:33:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/"},"modified":"2025-07-03T17:33:20","modified_gmt":"2025-07-03T21:33:20","slug":"hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/","title":{"rendered":"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">July 3, 2025<\/span><\/span> \/PRNewswire\/ &#8212; <b>Class Action Attorney <\/b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4462292-5&amp;h=2235735177&amp;u=https%3A%2F%2Fprofiles.superlawyers.com%2Fnew-york%2Fnew-york%2Flawyer%2Fjuan-e-monteverde%2Fb861d99b-d20f-4376-92c4-2996390bacbc.html&amp;a=Juan+Monteverde\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Juan Monteverde<\/span><\/a><b>\u00a0with <\/b><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4462292-5&amp;h=4290872266&amp;u=http%3A%2F%2Fwww.monteverdelaw.com%2F&amp;a=Monteverde+%26+Associates+PC\" target=\"_blank\" rel=\"nofollow\">Monteverde &amp; Associates PC<\/a>\u00a0(the &#8220;M&amp;A Class Action Firm&#8221;), has recovered millions of dollars for shareholders and is recognized as a <b>Top 50\u00a0Firm <\/b>in the 2024 ISS Securities Class Action Services Report. We are headquartered at the<b>\u00a0Empire State Building<\/b>\u00a0in <span class=\"xn-location\">New York City<\/span> and are investigating<\/p>\n<ul type=\"disc\">\n<li>\n          <b>Carisma Therapeutics Inc. (NASDAQ:\u00a0<\/b><br \/>\n          <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4462292-5&amp;h=3509353016&amp;u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FCARM%2F&amp;a=CARM\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <b>CARM<\/b><br \/>\n          <\/a><br \/>\n          <b>)<\/b>\u00a0related to its sale to OrthoCellix, Inc. Upon completion of the proposed transaction, existing Carisma shareholders are expected to own approximately 10% of the combined company.<\/li>\n<\/ul>\n<p>\n        <b>Click here for more information <\/b><br \/>\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4462292-5&amp;h=315710673&amp;u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fcarisma-therapeutics-inc%2F&amp;a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fcarisma-therapeutics-inc%2F\" target=\"_blank\" rel=\"nofollow\"><br \/>\n          <b>https:\/\/monteverdelaw.com\/case\/carisma-therapeutics-inc\/<\/b><br \/>\n        <\/a>. <b>It is free and there is no cost or obligation to you.<\/b><\/p>\n<ul type=\"disc\">\n<li>\n          <b>Guaranty\u00a0Bancshares, Inc. (NYSE:<\/b>\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4462292-5&amp;h=2372492019&amp;u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FGNTY%2F&amp;a=GNTY\" target=\"_blank\" rel=\"nofollow\"><b>GNTY<\/b><\/a><b>)<\/b>\u00a0related to its sale to Glacier Bancorp, Inc. Upon completion of the proposed transaction, existing Guaranty shareholders will receive 1.0000 share of Glacier common stock for each share of Guaranty (subject to certain adjustments).<\/li>\n<\/ul>\n<p>\n        <b>Click here for more<\/b><br \/>\n        <b>information <\/b><br \/>\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4462292-5&amp;h=3718615550&amp;u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fguaranty-bancshares-inc%2F&amp;a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fguaranty-bancshares-inc%2F\" target=\"_blank\" rel=\"nofollow\"><br \/>\n          <b>https:\/\/monteverdelaw.com\/case\/guaranty-bancshares-inc\/<\/b><br \/>\n        <\/a><br \/>\n        <b>.<\/b><br \/>\n        <b>It is free and there is no cost or obligation to you.<\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <b>Turnstone Biologics Corp. (NASDAQ:\u00a0<\/b><br \/>\n          <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4462292-5&amp;h=812985447&amp;u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FTSBX%2F&amp;a=TSBX\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <b>TSBX<\/b><br \/>\n          <\/a><br \/>\n          <b>)\u00a0<\/b>related to its sale to XOMA Royalty Corporation in which existing Turnstone shareholders will receive <span class=\"xn-money\">$0.34<\/span> in cash per share and one non-transferable contingent value right.<\/li>\n<\/ul>\n<p>\n        <b>Click here for more<\/b><br \/>\n        <b>information <\/b><br \/>\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4462292-5&amp;h=3914238269&amp;u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fturnstone-biologics-corp%2F&amp;a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fturnstone-biologics-corp%2F\" target=\"_blank\" rel=\"nofollow\"><br \/>\n          <b>https:\/\/monteverdelaw.com\/case\/turnstone-biologics-corp\/<\/b><br \/>\n        <\/a><br \/>\n        <b>.<\/b>\u00a0<b>It is free and there is no cost or obligation to you.<\/b><\/p>\n<ul type=\"disc\">\n<li>\n          <b>Sage Therapeutics, Inc. (NASDAQ:\u00a0<\/b><br \/>\n          <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4462292-5&amp;h=4041103678&amp;u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FSAGE%2F&amp;a=SAGE\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <b>SAGE<\/b><br \/>\n          <\/a><br \/>\n          <b>)\u00a0<\/b>related to its sale to Supernus Pharmaceuticals, Inc. Upon completion of the proposed transaction, current Sage shareholders will receive <span class=\"xn-money\">$8.50<\/span> per share in cash, plus one non-tradable contingent value right collectively worth up to <span class=\"xn-money\">$3.50<\/span> per share in cash payable (i) <span class=\"xn-money\">$0.50<\/span> the first commercial sale of the drug Zurzuvae in <span class=\"xn-location\">Japan<\/span> to third-aprty consumers following regulatory approval on or before <span class=\"xn-chron\">June 30, 2026<\/span>; (ii) <span class=\"xn-money\">$1.00<\/span> when net sales of Zurzuvae reach or exceed <span class=\"xn-money\">$300 million<\/span> in the U.S. on or before <span class=\"xn-chron\">December 31, 2028<\/span>; and (iii) <span class=\"xn-money\">$1.00<\/span> when net sales of Zurzuvae reach or exceed <span class=\"xn-money\">$375 million<\/span> in the U.S. on or before <span class=\"xn-chron\">December 31, 2030<\/span>.<\/li>\n<\/ul>\n<p>\n        <b>Click here for more information <\/b><br \/>\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4462292-5&amp;h=2544077366&amp;u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fsage-therapeutics-inc%2F&amp;a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fsage-therapeutics-inc%2F\" target=\"_blank\" rel=\"nofollow\"><br \/>\n          <b>https:\/\/monteverdelaw.com\/case\/sage-therapeutics-inc\/<\/b><br \/>\n        <\/a><br \/>\n        <b>. It is free and there is no cost or obligation to you.<\/b>\n      <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder7841\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.jpg\" title=\"Monteverde &amp; Associates PC Logo\" alt=\"Monteverde &amp; Associates PC Logo\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>NOT ALL LAW FIRMS ARE THE SAME. <\/b>Before you hire a law firm, you should talk to a lawyer and ask:<\/p>\n<ol type=\"1\">\n<li>Do you file class actions and go to Court?<\/li>\n<li>When was the last time you recovered money for shareholders?<\/li>\n<li>What cases did you recover money in and how much?<\/li>\n<\/ol>\n<p>\n        <b>About Monteverde &amp; Associates PC<\/b>\n      <\/p>\n<p>Our firm litigates and has recovered money for shareholders\u2026and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S.\u00a0Supreme Court.\u00a0<\/p>\n<p>\n        <b>No company, director or officer is above the law.<\/b>\u00a0If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4462292-5&amp;h=2622322971&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2721435-1%26h%3D2503619756%26u%3Dhttps%253A%252F%252Fwww.monteverdelaw.com%252F%26a%3Dwebsite&amp;a=website\" target=\"_blank\" rel=\"nofollow\"><b>website<\/b><\/a>\u00a0or contact <span class=\"xn-person\">Juan Monteverde, Esq.<\/span> either via e-mail at <a href=\"mailto:jmonteverde@monteverdelaw.com\" target=\"_blank\" rel=\"nofollow\"><b>jmonteverde@monteverdelaw.com<\/b><\/a>\u00a0or by telephone at (212) 971-1341.<\/p>\n<p>Contact:<br \/><span class=\"xn-person\">Juan Monteverde, Esq.<\/span><br \/>MONTEVERDE &amp; ASSOCIATES PC<br \/><b>The Empire State Building<br \/><\/b>350 Fifth Ave. Suite 4740<br \/><span class=\"xn-location\">New York, NY<\/span> 10118<br \/><span class=\"xn-location\">United States of America<\/span><br \/><a href=\"mailto:jmonteverde@monteverdelaw.com\" target=\"_blank\" rel=\"nofollow\">jmonteverde@monteverdelaw.com<\/a><br \/>Tel: (212) 971-1341<\/p>\n<p>Attorney Advertising. (C) 2025 Monteverde &amp; Associates PC.\u00a0The law firm responsible for this advertisement is Monteverde &amp; Associates PC (<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4462292-5&amp;h=4124654134&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2721435-1%26h%3D4276761662%26u%3Dhttp%253A%252F%252Fwww.monteverdelaw.com%252F%26a%3Dwww.monteverdelaw.com&amp;a=www.monteverdelaw.com\" target=\"_blank\" rel=\"nofollow\">www.monteverdelaw.com<\/a>). Prior results do not guarantee a similar outcome with respect to any future matter.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC24028&amp;sd=2025-07-03\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage-302497917.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage-302497917.html<\/a><\/p>\n<p>SOURCE  Monteverde &amp; Associates PC<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DC24028&amp;Transmission_Id=202507031730PR_NEWS_USPR_____DC24028&amp;DateId=20250703\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , July 3, 2025 \/PRNewswire\/ &#8212; Class Action Attorney Juan Monteverde\u00a0with Monteverde &amp; Associates PC\u00a0(the &#8220;M&amp;A Class Action Firm&#8221;), has recovered millions of dollars for shareholders and is recognized as a Top 50\u00a0Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the\u00a0Empire State Building\u00a0in New York City and are investigating Carisma Therapeutics Inc. (NASDAQ:\u00a0 CARM )\u00a0related to its sale to OrthoCellix, Inc. Upon completion of the proposed transaction, existing Carisma shareholders are expected to own approximately 10% of the combined company. Click here for more information https:\/\/monteverdelaw.com\/case\/carisma-therapeutics-inc\/ . It is free and there is no cost or obligation to you. Guaranty\u00a0Bancshares, Inc. (NYSE:\u00a0GNTY)\u00a0related to its sale to Glacier Bancorp, Inc. Upon &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;$HAREHOLDER ALERT: The M&amp;A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-866626","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>$HAREHOLDER ALERT: The M&amp;A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , July 3, 2025 \/PRNewswire\/ &#8212; Class Action Attorney Juan Monteverde\u00a0with Monteverde &amp; Associates PC\u00a0(the &#8220;M&amp;A Class Action Firm&#8221;), has recovered millions of dollars for shareholders and is recognized as a Top 50\u00a0Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the\u00a0Empire State Building\u00a0in New York City and are investigating Carisma Therapeutics Inc. (NASDAQ:\u00a0 CARM )\u00a0related to its sale to OrthoCellix, Inc. Upon completion of the proposed transaction, existing Carisma shareholders are expected to own approximately 10% of the combined company. Click here for more information https:\/\/monteverdelaw.com\/case\/carisma-therapeutics-inc\/ . It is free and there is no cost or obligation to you. Guaranty\u00a0Bancshares, Inc. (NYSE:\u00a0GNTY)\u00a0related to its sale to Glacier Bancorp, Inc. Upon &hellip; Continue reading &quot;$HAREHOLDER ALERT: The M&amp;A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-03T21:33:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE\",\"datePublished\":\"2025-07-03T21:33:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\\\/\"},\"wordCount\":598,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/443626\\\/Monteverde_Associates_PC_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\\\/\",\"name\":\"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/443626\\\/Monteverde_Associates_PC_Logo.jpg\",\"datePublished\":\"2025-07-03T21:33:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/443626\\\/Monteverde_Associates_PC_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/443626\\\/Monteverde_Associates_PC_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/","og_locale":"en_US","og_type":"article","og_title":"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - Market Newsdesk","og_description":"PR Newswire NEW YORK , July 3, 2025 \/PRNewswire\/ &#8212; Class Action Attorney Juan Monteverde\u00a0with Monteverde &amp; Associates PC\u00a0(the &#8220;M&amp;A Class Action Firm&#8221;), has recovered millions of dollars for shareholders and is recognized as a Top 50\u00a0Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the\u00a0Empire State Building\u00a0in New York City and are investigating Carisma Therapeutics Inc. (NASDAQ:\u00a0 CARM )\u00a0related to its sale to OrthoCellix, Inc. Upon completion of the proposed transaction, existing Carisma shareholders are expected to own approximately 10% of the combined company. Click here for more information https:\/\/monteverdelaw.com\/case\/carisma-therapeutics-inc\/ . It is free and there is no cost or obligation to you. Guaranty\u00a0Bancshares, Inc. (NYSE:\u00a0GNTY)\u00a0related to its sale to Glacier Bancorp, Inc. Upon &hellip; Continue reading \"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-03T21:33:20+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE","datePublished":"2025-07-03T21:33:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/"},"wordCount":598,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/","name":"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.jpg","datePublished":"2025-07-03T21:33:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-investigates-the-merger-carm-gnty-tsbx-and-sage\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/866626","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=866626"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/866626\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=866626"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=866626"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=866626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}